• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Others

    Kriya Appoints Sachiyo Minegishi As Chief Financial Officer

    GLOBENEWSWIRE

    Kriya Appoints Greg Di Russo, MD As Chief Medical Officer

    GLOBENEWSWIRE

    Kriya Secures $320M Series D for Chronic Disease Gene Therapies

    GLOBENEWSWIRE

    Kriya Announces Thirteen Presentations at ASGCT Annual Meeting

    GLOBENEWSWIRE

    Kriya Appoints Scientific Co-Founder J. Fraser as Chief Gene Therapy Officer

    GLOBENEWSWIRE

    Kriya Appoints Katherine Eade As Chief Legal Officer

    GLOBENEWSWIRE

    Kriya Announces 6 Presentations At ASGCT 2024

    GLOBENEWSWIRE

    Kriya Provides Update on Pipeline Progress

    GLOBENEWSWIRE

    Kriya to Present at the J.P. Morgan 42nd Annual Healthcare Conference

    GLOBENEWSWIRE

    Kriya Announces $150 Million Addition to its Series C

    GLOBENEWSWIRE

    Kriya to Present 10 Abstracts at the 2023 ASGCT Annual Meeting

    BUSINESSWIRE

    Kriya buys Redpin to chart gene therapy course in neurology

    FIERCEBIOTECH

    Kriya Appoints Curt Herberts as President and Chief Operating Officer

    BUSINESSWIRE

    Kriya banks $270M series C to be one-stop shop in gene therapy

    FIERCEBIOTECH

    Twist`s antibodies to wind up with Kriya`s AAV gene therapies

    FIERCEBIOTECH

    Kriya Appoints Ma’an Muhsin, as President & CMOr of Oncology Division

    BUSINESSWIRE

    Kriya Licenses Next Generation Complement-Targeted Gene Therapies

    BUSINESSWIRE

    Kriya Expands Gene Therapy Pipeline, Establishes Rare Disease Therapeutic Area

    BUSINESSWIRE

    Kriya Appoints Theresa Heah as CMO and President of Kriya Ophthalmology

    BUSINESSWIRE

    Kriya Completes Renovation of Facility for Scalable Gene Therapy Manufacturing

    BUSINESSWIRE

    Imago BioSciences, Inc. Announces Pricing of Upsized Initial Public Offering

    PHARMACEUTICAL TECHNOLOGHY

    Kriya Therapeutics Completes $100 Million Series B Financing

    BUSINESS WIRE

    Kriya Therapeutics Completes $100 Million Series B Financing

    BUSINESS WIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.